Grant Directory

Verified government funding opportunities

NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)

Open

National Institutes of Health

Deadline: Sep 5, 2027federal

Updated: Oct 30, 2025

Summary

The grant aims to support small businesses in conducting exploratory clinical trials for investigational agents that align with the NINDS strategic plan and clinical research interests. Eligible applicants are small businesses, while non-domestic entities and foreign components of U.S. organizations are not eligible to apply. Application details are not provided in the description; interested parties should refer to the full opportunity announcement for more information.

Full Description

This announcement encourages small business applications for exploratory clinical trials of investigational agents (drugs, biologics, surgical therapies or devices) that may contribute to the justification for and provide the data required for designing clinical studies. Diseases chosen for study should be based on the NINDS strategic plan and clinical research interests (www.ninds.nih.gov/funding/areas/index.htm).

Eligibility

Eligible applicants

Business

  • Small businesses

Additional information

Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

Grantor contact information

Description

NIH Grants Information grantsinfo@nih.gov

Email

See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.

grantsinfo@nih.gov

Apply on official siteUpdated Oct 30, 2025

Recommended Resource

Grant Writing Services on Fiverr

Top Pick

Struggling with grant applications? Get expert help from professional freelance writers on Fiverr — from research and proposal drafts to compliance review and submission. Secure funding faster with proven talent.